Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. èììóíèòåò
    îò Amon â ðàçäåëå Àëëåðãèÿ, èììóíîëîãèÿ
    Îòâåòîâ: 0
    : 16.03.2006, 11:02
  2. èììóíèòåò
    îò kniaginia â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 10
    : 01.06.2005, 20:05
  3. Èììóíèòåò
    îò Ñàìà ñåáå õîçÿéêà â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 17
    : 25.05.2005, 14:31
  4. èììóíèòåò
    îò shcnik â ðàçäåëå Ýíäîêðèíîëîã
    Îòâåòîâ: 4
    : 01.09.2004, 19:30
  5. Èììóíèòåò
    îò Oleg â ðàçäåëå Òåðàïåâò
    Îòâåòîâ: 1
    : 08.08.2003, 17:53
  1. Alexey
    #91
    ×èòàòåëü Íåäóã.Ðó
    ×òî ñàìîå óæàñíîå, èììóíîìîäóëÿòîðû íàïðàâî è íàëåâî íàçíà÷àþò ïðîâèçîðû â àïòåêàõ. È áîëüíûå ïîêóïàþò. Êàê çàìàí÷èâî çâó÷èò "äëÿ ïîâûøåíèÿ èììóíèòåòà".

  2. kaleka
    #92
    ×èòàòåëü Íåäóã.Ðó
    Ïðîñòî äåâî÷êà òàê ïûòàåòñÿ ñàìîóòâåðäèòüñÿ.

    Ñ óâàæåíèåì/Sincerely yours

    Èâàí Êîêîòêèí HERPES.RU Ãëàâíûé ðåäàêòîð.

    E-Mail: boss@herpes.ru Moscow, Russia.

    Web : http://gerpes.ru/about/ivkoko

    Íàïèøè ïðîùå - "Ñ óâàæåíèåì, Âàíÿ"

  3. Alex978
    #93
    ×èòàòåëü Íåäóã.Ðó
    Ñ ïîñóòè áåçðåöåïòóðíîé ïðîäàæåé èììóíîìîäóëÿòîðîâ è íàçíà÷åíèåì ýòîé ãðóïïû ïðåïàðàòîâ ïðîâèçîðàìè è ôàðìàöåâòàìè, íåñîìåííî ñëåäóåò áîðîòüñÿ.

  4. Netto4ka
    #94
    ×èòàòåëü Íåäóã.Ðó
    Àëîí!

    Íà Âàøå áðàâèðîâàíèå «ñåðòèôèêàòîì», êîòîðîå äàåò ïðàâî îáî âñåì è îáî âñåõ âûñîêîìåðíî, ïîðîé íåöåíçóðíî ñóäèòü – ó ìåíÿ èðîíèè íå õâàòàåò.

    Òî, ÷òî Âû êîãäà-òî âûó÷èëè è ïåðåñêàçàëè (î âèðóñàõ, èììóíèòåòå), òî, ÷òî äðóãèå îòêðûëè, èçó÷èëè è Âàì íà ïàëüöàõ, ïîïðîùå, ÷åðåç ó÷åáíèêè ðàññêàçàëè, åù¸ íå îáîçíà÷àåò, ÷òî âñå îñòàëüíûå äèëåòàíòû.  ÷àñòíîñòè, åñëè Çàéöåâ è äèëåòàíò (÷òî, íåñîìíåííî) â òåõ èëè èíûõ âîïðîñàõ - ñóäèòü òî îá ýòîì íå Âàì.

    ×òî êàñàåòñÿ ýêñïåðèìåíòîâ íàä ëþäüìè. Âû, êàæåòñÿ, óæå ñàäèëèñü â ëóæó.

    http://forums./showpost.php?p=120836&postcount=155

    À òóò, âàõ, îêàçûâàþòñÿ óæå äàâíî èäóò «ýêñïåðèìåíòû» íàä íåñ÷àñòíûìè èçðàèëüñêèìè äåòüìè, òèïà

    Pediatrics, 2005 Jan, 115(1), 5 - 9

    Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents; Weizman Z et al.; OBJECTIVE: To investigate the effect of 2 different species of probiotics in preventing infections in infants attending child care centers . METHODS: A double-blind, placebo-controlled, randomized trial was conducted from December 1, 2000, to September 30, 2002, at 14 child care centers in the Beer-Sheva area of Israel in healthy term infants 4 to 10 months old . Infants were assigned randomly to formula supplemented with Bifidobacterium lactis (BB-12), Lactobacillus reuteri (American Type Culture Collection 55730), or no probiotics . Duration of feeding, including follow-up, for each participant was 12 weeks . All infants were fed only the assigned formula and were not breastfed due to parental decision before recruitment to the study . Probiotic or prebiotic food products or supplements were not allowed . Main outcome measures were number of days and number of episodes with fever (>38 degrees C) and number of days and number of episodes with diarrhea or respiratory illness . RESULTS: Participants (n = 201) were similar regarding gestational age, birth weight, gender, and previous breastfeeding . The controls (n = 60), compared with those fed B lactis (n = 73) or L reuteri (n = 68), had significantly more febrile episodes (mean {95% confidence interval}: 0.41 {0.28-0.54} vs 0.27 {0.17-0.37} vs 0.11 {0.04-0.18}, respectively) . The controls also had more diarrhea episodes (0.31 {0.22-0.40} vs 0.13 {0.05-0.21} vs 0.02 {0.01-0.05}, respectively) and episodes of longer duration (0.59 {0.34-0.84} vs 0.37 {0.08-0.66} vs 0.15 {0.12-0.18} days, respectively) . The L reuteri group, compared with BB-12 or controls, had a significant decrease of number of days with fever, clinic visits, child care absences, and antibiotic prescriptions . Rate and duration of respiratory illnesses did not differ significantly between groups . CONCLUSIONS: Child care infants fed a formula supplemented with L reuteri or B lactis had fewer and shorter episodes of diarrhea, with no effect on respiratory illnesses . These effects were more prominent with L reuteri, which was also the only supplement to improve additional morbidity parameters.

  5. Âÿ÷åñëàâ
    #95
    ×èòàòåëü Íåäóã.Ðó
    Åñëè è äàëüøå íà ôîðóìå áóäóò èäòè ëè÷íûå ðàçáîðêè, ÿ áóäó âûíóæäåí çàêðûòü òåìó.

  6. Íàäåæäà Ôîêèíà
    #96
    ×èòàòåëü Íåäóã.Ðó
    Àëîí!

    À òóò, âàõ, îêàçûâàþòñÿ óæå äàâíî èäóò «ýêñïåðèìåíòû» íàä íåñ÷àñòíûìè èçðàèëüñêèìè äåòüìè, òèïà

    Pediatrics, 2005 Jan, 115(1), 5 - 9

    Ãîñïîäè áîæå ìîé, ãîñïîäèí Çàéöåâ, î ÷åì âû îïÿòü? Ïîâòîðÿþ, ìíîãèå ãîäû âû â ñîñòàâå ïðåñòóïíîé ãðóïïû ïðîâîäèëè îïûòû íà íå ïîäîçðåâàþùèõ îá ýòîì ëþäÿõ. È ïðîäîëæàåòå äåëàòü ýòî, íåñìîòðÿ íè íà ÷òî, ðàññóæäàÿ ïðè ýòîì î ÷åñòè è ñîâåñòè. Ïðèâåäåííàÿ âàìè ññûëêà, íå ñîäåðæèò óêàçàíèÿ íà ïîäîáíûå äåéñòâèÿ. Óâåðÿþ âàñ, ÷òî âñå íåîáõîäèìûå â ïîäîáíûõ ñëó÷àÿõ ïðîöåäóðû, âêëþ÷àÿ çàêëþ÷åíèå "õåëüñèíêè", áûëè ïîëó÷åíû. Âû ïðîñòî, êàê îáû÷íî, íå èìååòå íè ìàëåéøåãî ïîíÿòèÿ î òîì ,î ÷åì â î÷åðåäíîé ðàç ôàíòàçèðóåòå.

  7. oha75
    #97
    ×èòàòåëü Íåäóã.Ðó
    Ïðîñòî äåâî÷êà òàê ïûòàåòñÿ ñàìîóòâåðäèòüñÿ.



    Çàéöåâ - íå äåâî÷êà

  8. Ìèøà24
    #98
    ×èòàòåëü Íåäóã.Ðó
    Àëîí!

    Ïîâòîðÿòü, ñêîëüêî è êàêèõ ýêñïåðèìåíòàëüíûõ ðàáîò áûëî ïî âñåì òðåáîâàíèÿì ïðîâåäåíî äî «êëèíèêè». ×òî äî îôèöèàëüíîãî ââåäåíèÿ â ðååñòð, äâàæäû â ðàçëè÷íûõ êëèíèêàõ (âñåãî 6), óêàçàííûõ ÌÇ ÑÑÑÐ, ïðîâîäèëèñü îïÿòü òàêè ïî âñåì (íà òîò ïåðèîä!!!) ïðàâèëàì êëèíè÷åñêèå èñïûòàíèÿ – ëåíü. Òîò, êòî íå õî÷åò óñëûøàòü, âñ¸ ðàâíî íå óñëûøèò.



    À èçðàèëüñêóþ ðàáîòó (êàê äðóãèå) ÿ íàïîìíèë ëèøü â ñâÿçè ñ Âàøåé êðûëàòî¸ ôðàçîé – äèñáàêòåðèîç (÷èòàé íàðóøåíèÿ ìèêðîáèîöåíîçà) - «âûìûñåë, ñóùåñòâóþùèé ëèøü â óìàõ ðîññèéñêèõ äîêòîðîâ».

    Ê ñëîâó, ê âîïðîñó î äèëåòàíòàõ – âåäóùåãî íàó÷íîãî ñîòðóäíèêà ÍÖÑÑÕ èì Áàêóëåâà, ìèêðîáèîëîãà, äîêòîðà íàóê, êîòîðûé âñþ æèçíü ïðîôåññèîíàëüíî çàíèìàåòñÿ ðàçëè÷íîé ìèêðîôëîðîé â îðãàíèçìå ÷åëîâåêà çàáàíèëè òîëüêî çà óïîòðåáëåíèå ýòîãî òåðìèíà. Ïðè÷åì, â îñíîâíîì óñèëèÿìè òîé æå ßíû, êîòîðàÿ è â ìèêðîáèîöåíîçå, íàðÿäó ñ èììóíîëîãèåé, îêàçûâàåòñÿ êðóïíåéøèé ñïåöèàëèñò. Âîò ýòî êàê ðàç ââåðõ ïîðÿäî÷íîñòè â íàøåì ÄÊ.

  9. Àâàòàð äëÿ nedug136455 Ìíîãîóâàæàåìûé
    ñîîáùåíèé
    161
    Öèòàòà Ñîîáùåíèå îò sergyk911 Ïîñìîòðåòü ñîîáùåíèå
    ß ïðîñòóæàþñü ïðàêòè÷åñêè êàæäûé ìåñÿö
    à äîëãî ïîòîì áîëååòå?

  10. Àâàòàð äëÿ nedug110229 Íîâè÷îê
    ñîîáùåíèé
    4
    Ëþäè õîòü êàê-òî ïûòàþòñÿ ïîäíÿòü ñâîé èììóíèòåò, âîò è ïîëüçóþòñÿ èììóíîìîäóëÿòîðàì. ß îáðàòèëà âíèìàíèå, ÷òî åñëè ïðè ïåðâûõ ñèìïòîìàõ ïðîñòóäû íà÷èíàþ ïðèíèìàòü ýðãîôåðîí, òî âûçäîðàâëèâàþ íàìíîãî áûñòðåå è îñëîæíåíèÿ íå ðàçâèâàþòñÿ

  11. Àâàòàð äëÿ nedug147263 Çàñëóæåííûé
    ñîîáùåíèé
    60
    Íî ïðè÷èíû ñíèæåííîãî èìóíèòåòà ìîãóò áûòü ðàçíûìè. Òîò æå âè÷ íàïðèìåð èëè äðóãèå ïîäîáíûå çàáîëåâàíèÿ. Òàê ÷òî ÿ áû íà âàøåì ìåñòå íå äåëàëà áû òàêèõ ïîñïåøíûõ âûâîäîâ, íå çíàÿ âñåé êàðòèíû, ïî ìîåìó îïûòó, èììóíîìîäóëÿòîðû èíîãäà î÷åíü äàæå ïîìîãàþò

  12. Àâàòàð äëÿ nedug156754 Çàñëóæåííûé
    ñîîáùåíèé
    83
    Öèòàòà Ñîîáùåíèå îò nedug147263 Ïîñìîòðåòü ñîîáùåíèå
    Íî ïðè÷èíû ñíèæåííîãî èìóíèòåòà ìîãóò áûòü ðàçíûìè. Òîò æå âè÷ íàïðèìåð èëè äðóãèå ïîäîáíûå çàáîëåâàíèÿ. Òàê ÷òî ÿ áû íà âàøåì ìåñòå íå äåëàëà áû òàêèõ ïîñïåøíûõ âûâîäîâ, íå çíàÿ âñåé êàðòèíû, ïî ìîåìó îïûòó, èììóíîìîäóëÿòîðû èíîãäà î÷åíü äàæå ïîìîãàþò
    Ó ìåíÿ åñòü äðóãàÿ èíôîðìàöèÿ. Ñ÷èòàåòñÿ, ÷òî èììóíîìîäóëÿòîðû ýòî ÷èñòî ìàðêåòèíã.

  13. Àâàòàð äëÿ nedug163163 Ìíîãîóâàæàåìûé
    ñîîáùåíèé
    290
    Öèòàòà Ñîîáùåíèå îò nedug156754 Ïîñìîòðåòü ñîîáùåíèå
    Ó ìåíÿ åñòü äðóãàÿ èíôîðìàöèÿ. Ñ÷èòàåòñÿ, ÷òî èììóíîìîäóëÿòîðû ýòî ÷èñòî ìàðêåòèíã.
    Ñîãëàñíà. È òî, ÷òî îíè êîìó-òî ïîìîãàþò ýòî ñêîðåå èñêëþ÷åíèå, ÷åì ïðàâèëî

  14. Àâàòàð äëÿ nedug163165 Ìóäðåö
    ñîîáùåíèé
    300
    Öèòàòà Ñîîáùåíèå îò nedug163163 Ïîñìîòðåòü ñîîáùåíèå
    Ñîãëàñíà. È òî, ÷òî îíè êîìó-òî ïîìîãàþò ýòî ñêîðåå èñêëþ÷åíèå, ÷åì ïðàâèëî
    Íó êàê äîïîëíåíèå ê îñíîâíîé òåðàïèè ñêîðåå âñåãî, ïëþñ îáðàç æèçíè çäîðîâûé íàäî âåñòè.

  15. Àâàòàð äëÿ nedug163164 Ìóäðåö
    ñîîáùåíèé
    300
    Öèòàòà Ñîîáùåíèå îò nedug110229 Ïîñìîòðåòü ñîîáùåíèå
    Ëþäè õîòü êàê-òî ïûòàþòñÿ ïîäíÿòü ñâîé èììóíèòåò, âîò è ïîëüçóþòñÿ èììóíîìîäóëÿòîðàì. ß îáðàòèëà âíèìàíèå, ÷òî åñëè ïðè ïåðâûõ ñèìïòîìàõ ïðîñòóäû íà÷èíàþ ïðèíèìàòü ýðãîôåðîí, òî âûçäîðàâëèâàþ íàìíîãî áûñòðåå è îñëîæíåíèÿ íå ðàçâèâàþòñÿ
    ß ïðè ïåðâûõ ñèìïòîìàõ ïðîñòóäû ñðàçó íà÷èíàþ ïîëîñêàòü ãîðëî ðàçíûìè òðàâàìè. Î÷åíü ïîìîãàåò âñåãäà ñìÿã÷èòü òå÷åíèå áîëåçíè.

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •